Tal Fligelman

Tel Aviv University

Papers

2

Total Citations

25

H-Index

2

About

Dr. Tal Fligelman is a leading researcher in female pelvic medicine and reconstructive surgery, with a focused expertise in the surgical management of pelvic organ prolapse (POP) and its associated complications. Her work critically examines the outcomes of robotic-assisted laparoscopic sacrocolpopexy, particularly identifying that advanced cystocele is a significant risk factor for surgical failure—a finding that has shaped preoperative counseling and surgical planning. Dr. Fligelman also investigates persistent overactive bladder symptoms following prolapse repair, revealing key predictors that help clinicians manage patient expectations and optimize postoperative care. Her most-cited studies, including the 2021 paper on cystocele as a risk factor (16 citations) and the 2022 work on overactive bladder predictors (9 citations), have been instrumental in refining surgical techniques and improving quality of life for women with complex pelvic floor disorders. Through her rigorous outcomes research, Dr. Fligelman continues to advance evidence-based practices in urogynecology, making her a valuable voice for both clinicians and patients navigating the challenges of pelvic reconstructive surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
25
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Advanced Cystocele is a Risk Factor for Surgical Failure after Robotic-assisted Laparoscopic Sacrocolpopexy
16 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Tel Aviv University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago